ENTERO
1 call
Concalls & earnings callsEntero Healthcare Solutions Limited
Every summarised call, newest first. Latest is Q1 FY27, held 10 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Entero delivered a strong start to FY27, exceeding full-year margin guidance in Q1 with 38.2% revenue growth and a 143 bps expansion in EBITDA margin to 5%, driven by scale, mix, and deliberate portfolio actions.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹1,940 Cr | 38.2% YoY | |
| EBITDA Margin | 5% | 143 bps YoY | |
| PAT | ₹52 Cr | 72% YoY | |
| PAT (Attributable to Owners) | ₹38 Cr | 37% YoY |
Latest guidance
- FY27 consolidated revenue growth of approximately 23% year-on-year, excluding any contribution from new acquisitions.
- FY27 EBITDA margin of 5%.
- FY27 EBITDA to operating cash flow conversion of 50%.
- MedTech revenue on track to cross INR 1,000 crores in FY27 on an organic basis.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹1,359.00 Cr+36.9% YoY+4.5% QoQ | ₹29.45 Cr+321.9% YoY+13.1% QoQ | ₹5.85+206.3% YoY+7.7% QoQ |
| Q2 FY25 | ₹1,300.69 Cr— YoY+18.6% QoQ | ₹26.03 Cr— YoY+26.8% QoQ | ₹5.43— YoY+17.5% QoQ |
| Q1 FY25 | ₹1,097.04 Cr— YoY+6.1% QoQ | ₹20.53 Cr— YoY-3.1% QoQ | ₹4.62— YoY-19.4% QoQ |
| Q4 FY24 | ₹1,034.18 Cr— YoY+4.2% QoQ | ₹21.18 Cr— YoY+203.4% QoQ | ₹5.73— YoY+200% QoQ |
| Q3 FY24 | ₹992.63 Cr— YoY— QoQ | ₹6.98 Cr— YoY— QoQ | ₹1.91— YoY— QoQ |
Call history
- Q1 FY27Positive tone
Entero delivered a strong start to FY27, exceeding full-year margin guidance in Q1 with 38.2% revenue growth and a 143 bps expansion in EBITDA margin to 5%, driven by scale, mix, and deliberate portfolio actions.
- Revenue
- ₹1,940 Cr38.2% YoY
- EBITDA Margin
- 5%143 bps YoY